Skeletal bone morphology is resistant to the high amplitude seasonal leptin cycle in the Siberian hamster

Journal of Endocrinology

Volumn 186, Issue 3, 2005, Pages 475-479

  Rousseau, K ^a   Atcha, Z ^a   Denton, J ^a   Cagampang, F R A ^a,b   Ennos, A R ^a   Freemont, A J ^a   Loudon, Andrew S I ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PHOSPHATE BUFFERED SALINE;

ACTION POTENTIAL; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE BOWING; BONE MASS; BONE METABOLISM; BONE TISSUE; BREEDING; COMPRESSION; CONTROLLED STUDY; DATA ANALYSIS; EXPOSURE; HORMONE BLOOD LEVEL; INFUSION; MALE; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; OBESITY; OSMOTIC PUMP; PHODOPUS; PHOTOPERIODICITY; PRIORITY JOURNAL; REGULATORY MECHANISM; SEASONAL VARIATION; TRABECULAR BONE; WEIGHT REDUCTION;

ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE AND BONES; CRICETINAE; FEMALE; INFUSIONS, INTRAVENOUS; LEPTIN; MALE; PHODOPUS; PHOTOPERIOD; REPRODUCTION; SEASONS;

EID: 26044471829     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06207     Document Type: Article

References (23)

1. Atcha Z, Cagampang FRA, Stirland JA, Morris ID, Brooks AN, Ebling FJ, Klingenspor M & Loudon ASI 2000 Leptin acts on metabolism in a photoperiod-dependent manner, but has no effect on reproductive function in the seasonally breeding Siberian hamster (Phodopus sungorus). Endocrinology 141 4128-4135.
2. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL & Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142 3546-3553.
3. Byers RJ, Denton J, Hoyland JA & Freemont AJ 1999 Differential patterns of altered bone formation in different bone compartments in established osteoporosis. Journal of Clinical Pathology 52 23-28.
4. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC & Reid IR 2002 Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. Journal of Endocrinology 175 405-415.
5. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM & Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 197-207.
6. Ebling FJ 1994 Photoperiodic differences during development in the dwarf hamsters Phodopus sungorus and Phodopus campbelli. General and Comparative Endocrinology 95 475-482.
7. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J & Karsenty G 2004 Serum leptin level is a regulator of bone mass. PNAS 101 3258-3263.
8. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM & O'Rahilly S 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 110 1093-1103.
9. Foldes J, Shih MS & Levy J 1992 Bone structure and calcium metabolism in obese Zucker rats. International Journal of Obesity and Related Metabolic Disorders 16 95-102.
10. Gordeladze JO, Drevon CA, Syversen U & Reseland JE 2002 Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. Journal of Cellular Biochemistry 85 825-836.
11. Khosla S 2002 Editorial: Leptin - Central or peripheral to the regulation of bone metabolism? Endocrinology 143 4161-4164.
12. Liu C, Grossmann A, Bain S, Strachan M, Puerner C, Bailey C, Humes J, Lenox J, Yamamoto G, Sprugel K, Kujiper J, Weigle S, Durnam D & Moore E 1997 Leptin stimulates cortical bone formation in obese (ob/ob) mice. Journal of Bone and Mineral Research 12 S115.
13. Moran SA, Pattern N, Young JR, Cochran E, Sebring N, Reynolds J, Premkumar A, Depaoli AM, Skarulis MC, Oral EA & Gorden P 2004 Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism 53 513-519.
14. Picherit C, Horcajada MN, Mathey J, Chanteranne B, Puel C, Lebecque P, Davicco MJ, Coxam V & Barlet JP 2003 Isoflavone consumption does not increase the bone mass in osteopenic obese female Zucker rats. Annals of Nutrition and Metabolism 47 70-77.
15. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO & Drevon CA 2001 Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. Journal of Bone and Mineral Research 16 1426-1433.
16. Rousseau K, Atcha Z, Cagampang FRA, Le Rouzic P, Stirland JA, Ivanov TR, Ebling FJP, Klingenspor M & Loudon ASI 2002 Photoperiodic regulation of leptin resistance in the seasonally breeding Siberian hamster (Phodopus sungorus). Endocrinology 143 3083-3095.
17. Rousseau K, Atcha Z & Loudon ASI 2003 Leptin and seasonal mammals. Journal of Neuroendocrinology 15 409-414.
18. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ & Baskin DG 2000 Central nervous system control of food intake. Nature 404 661-671.
19. Simha V, Zerwekh JE, Sakhaee K & Garg A 2002 Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy. Journal of Clinical Endocrinology and Metabolism 87 4942-4945.
20. Steinlechner S, Heldmaier G & Becker H 1983 The seasonal cycle of body weight in the Djungarian hamster: photoperiodic control and the influence of starvation and melatonin. Oecologia 60 401-405.
21. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H & Swick AG 2000 Leptin is a potent stimulator of bone growth in ob/ob mice. Regulatory Peptides 92 73-78.
22. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P & Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111 305-317.
23. Thomas T 2004 The complex effects of leptin on bone metabolism through multiple pathways. Current Opinion in Pharmacology 4 295-300.